Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) — Stella
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(15 sites)
United States
University of California Los Angeles, Los Angeles, California
MedStar Health Research Institute, Washington D.C., District of Columbia
Bioresearch Partner, Doral, Florida
Emory University Hospital - GCRC, Atlanta, Georgia
University of Iowa Health Care, Iowa City, Iowa
Johns Hopkins Clinical Research Unit, Baltimore, Maryland
Mayo Clinic, Rochester, Minnesota
University of Nebraska Medical Center, Omaha, Nebraska
Columbia University Irving Medical Center, New York, New York
Duke University Hospital, Durham, North Carolina
Cleveland Clinic Foundation, Cleveland, Ohio
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Rhode Island Hospital, Providence, Rhode Island
Vanderbilt Center for Human Nutrition, Nashville, Tennessee